Carlos L Arteaga. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Antineoplastic Agents/therapeutic useClinical Trials as TopicEnzyme Inhibitors/therapeutic useErbB Receptors/antagonists & inhibitorsErbB Receptors/geneticsErbB Receptors/metabolismGefitinibHumansLung Neoplasms/drug therapyMutationPatient SelectionQuinazolines/therapeutic use
Substances: See more » Antineoplastic AgentsEnzyme InhibitorsQuinazolinesErbB ReceptorsGefitinib
Year: 2004 PMID: 15170197 DOI: 10.1038/nm0604-577
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440